-+ 0.00%
-+ 0.00%
-+ 0.00%

Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026

Barchart·08/18/2026 11:30:00
Listen to the news

Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting
on September 29, 2026

Halle (Saale) / Munich, Germany, August 18, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and fibrotic disorders, with a primary focus on kidney diseases, today announced that its 2026 Annual General Meeting will be held on Tuesday, September 29, 2026, at 11:00 a.m. (CEST) at the Amsterdam offices of NautaDutilh N.V.

The full agenda and all relevant documents are available on the Company's website: https://www.vivoryon.com/2026-annual-general-meeting/.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.